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Case report 50 
 51 
A 70-year-old male patient had a history of fever, epigastric and right flank pain of one 52 
month of evolution. One week prior to admission, residual choledochal microlithiasis 53 
without bile duct dilatation was found on echoendoscopy. The patient had a 54 
cholecystectomy 10 years before. 55 
On the night before the Emergency Room consultation, the patient had postprandial 56 
epigastralgia, fever and chills; therefore, his hospitalization was decided. During 57 
hospitalization, Endoscopic Retrograde Cholangiopancreatography (ERCP) was performed 58 
showing micro –gallstones. They were removed by Dormia basket and extraction balloon 59 
catheter. Admission diagnosis was cholangitis due to residual lithiasis.  60 
Admission laboratory findings were: white blood cell count: 4,900 /mm3 (with 86 % 61 
neutrophils), hematocrit: 37 %, kaolin partial thromboplastin time (KPTT) 34 sec and 62 
prothrombin time 70 %. Liver function tests were as follows: alanine aminotransferase 63 
(ALT), 716 U/L (normal, < 35 U/liter); aspartate aminotransferase (AST), 218 U/L 64 
(normal, < 35 U/L); total bilirubin, 0.7 mg/dL (normal, < 1.0 mg/dL); direct bilirubin 0.3 65 
(normal, < 0.3 mg/dL); alkaline phosphatase, 353 U/L (normal, < 279 U/L); total 66 
cholesterol 103 mg/dL (normal, 150-200 mg/dL). 67 
In two blood sample cultures taken on admission, after 24 hours of incubation, growth of 68 
Streptococcus infantarius with Escherichia coli was obtained. 69 
Phenotypic identification was carried out by conventional biochemical tests (1).The 70 
organism was identified as Streptococcus infantarius, however, it was not possible to 71 
determine the subspecies by this methodology. In addition, we used the GP card of the 72 
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VITEK 2 system (bioMerieux, Marcy-l_Etoile, France). The bionumber obtained was 73 
141011164717711, giving an identification of S. infantarius subsp coli; now Streptococcus 74 
lutetiensis (4)/Streptococcus bovis with an excellent confidence level. Identification was 75 
also carried out by matrix-assisted laser desorption ionization–time-of-flight (MALDITOF) 76 
mass spectrometry (MS) (Bruker Daltonik) showing a spectral score of 2.223 for 77 
Streptococcus lutetiensis (2). 78 
PCR amplification of the 16S rRNA was performed in order to reach definitive 79 
identification. PCR product of the 16S rRNA gene, using the primers described by 80 
Weisburg  et al. (3), was obtained with the Taq DNA polymerase based on the 81 
manufacturer's specifications (Promega). Sequencing of the 1.4 kb PCR product was 82 
performed on both DNA strands at Macrogen, Inc., Seoul, Korea sequencing facility. The 83 
sequences were analyzed using the Blast V2.0 software 84 
(http://www.ncbi.nlm.nih.gov/BLAST/), showing a 99% identity with the sequences 85 
corresponding either to the 16S RNA ribosomal gene S. infantarius subsp. infantarius 86 
(GenBank accession number EU420174) or to the 16S RNA ribosomal gene S. lutetiensis 87 
(GenBank accession number NR 037096). In order to discriminate subspecies, we 88 
amplified the sodA gene (coding for the manganese-dependent superoxide dismutase) 89 
following the methodology described by Poyart et al. (4, 5). A PCR product of 404 bp was 90 
obtained using the primers described by these authors (4, 5). Sequence analysis revealed 91 
100% identity with the sodA sequence of Streptococcus lutetiensis (GenBank accession No. 92 
AY035713). These results confirmed the species identification. 93 
Disk diffusion was performed following CLSI guidelines (6). Furthermore, susceptibility to 94 
7 antimicrobial agents was determined by the Etest technique (bioMérieux) on Mueller -95 
5 
 
Hinton agar with 5% sheep blood following the manufacturer’s specifications. The MIC 96 
breakpoints used in this study were those established by the Clinical and Laboratory 97 
Standards Institute CLSI 2012 (6) for Streptococcus spp. viridans group.  The MICs for S. 98 
lutetiensis isolate were as follows (µg/mL): penicillin 0.032; ceftriaxone 0.023; 99 
vancomycin 0.38; ciprofloxacin 0.75; erythromycin 0.064; clindamycin 2.0 and lincomycin 100 
128. 101 
The phenotypic characterization was complemented by a modified triple disk induction test 102 
as previously described (7). In the test, lincomycin and clindamycin disks were placed at 103 
the sides of an erythromycin disk 15 mm apart. No inhibition zones were observed around 104 
clindamycin and lincomycin disks; no inducible pattern was detected. 105 
To determine the lincosamide resistance mechanism (L-phenotype: erythromycin 106 
susceptible but clindamycin resistant), detection of lnuB gene, encoding the lincosamide 107 
nucleotidyl-transferase enzyme was performed. The presence of lnuB gene was detected 108 
using the previously described (8) primers and confirmed by sequencing. The nucleotide 109 
sequence was deposited in the EMBL/GenBank/DDBJ databases under accession number 110 
KC688833. 111 
Given the clinical picture of cholangitis (fever and epigastric and right flank pain), and with 112 
the preliminary report of Streptococcus infantarius with Escherichia coli isolation in blood 113 
cultures, treatment with ampicillin-sulbactam 3.0 g/6 hours/IV plus ciprofloxacin 400 114 
mg/12 hours/IV was started.  115 




After 3 days of treatment with this antimicrobial agent, the patient was afebrile and 118 
recovered well. He was discharged on ertapenem 1g/day i.v. for 15 days. 119 
 120 
In the nineties, and after several different proposals, the group Streptococcus bovis / 121 
equinus was reclassified based on their phenotypic and genotypic differences in: 122 
Streptococcus gallolyticus subsp. gallolyticus (9), formerly S. bovis biotype I; 123 
Streptococcus lutetiensis, previously known as Streptococcus infantarius subsp. coli (4), 124 
which in turn corresponds to S. bovis biotype II / 1, and finally Streptococcus gallolyticus 125 
subsp. pasteurianus (formerly S. bovis biotype II/2) (4). Species from this group are 126 
frequently encountered in blood cultures of patients with bacteremia, sepsis, and 127 
endocarditis.  The clinical significance S. bovis group growing in blood culture is based on 128 
the association of S. gallolyticus subsp. gallolyticus with gastrointestinal disorders 129 
including colon cancer and chronic liver disease and S. gallolyticus subsp. pasteurianus 130 
with meningitis (1, 10-12). Other species that are also part of this group but less related to 131 
men are Streptococcus equinus, Streptococcus gallolyticus subsp. macedonicus, 132 
Streptococcus infantarius subsp. infantarius, and Streptococcus alactolyticus (13). 133 
As regards S. bovis group antibiotic susceptibility, a high rate of resistance to erythromycin 134 
and to clindamycin in this group has previously been described by Rodríguez-Avial et al. 135 
(14). In their study, on a total of 18 isolates, 78% were resistant to erythromycin and 72% 136 
were resistant to clindamycin. Among their isolates, the cMLSB phenotype was the most 137 
predominant and in all of them, the erm(B) gene was detected; the iMLSB phenotype was 138 
only detected in one erythromycin-resistant isolate. Additionally, differences in the rates of 139 
resistance to erythromycin and clindamycin were observed among the different subspecies 140 
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of Streptococcus gallolyticus, S. infantarius subsp. infantarius and Streptococcus lutetiensis 141 
in the Romero et al. study (15).The highest percentage of resistance was obtained for S. 142 
lutetiensis (60 % resistant to erythromycin and to clindamycin, MIC50 > 2 µg/ml) (15). 143 
These results differ from those reported by Beck et al. (1). In their work, 94% of the 144 
isolates of S. lutetiensis tested were susceptible to erythromycin (MIC90 0.12 µg/ml) while 145 
clindamycin susceptibility was not reported (1). The highest percentages of erythromycin 146 
resistance were observed on S. gallolyticus subsp. gallolyticus (MIC90 > 32 µg/ml) isolates 147 
and on S. gallolyticus subsp. pasteurianus isolates (MIC90 > 32 µg/ml); however 148 
erythromycin resistance mechanism was not recorded by these authors (1). In our work, S. 149 
lutetiensis isolate was PCR positive only for lnuB gene, representing the first description of 150 
this gene within this species. Among streptococci, lnuB gene was also described in 151 
Streptococcus agalactiae (16, 17); Streptococcus dysgalactiae ssp. equisimilis and in 152 
Streptococcus uberis (18, 19). 153 
The difficulty to differentiate Streptococcus infantarius subspecies using conventional 154 
biochemical tests has been reported by other authors. Beck et al. (1) found that some 155 
features of S. infantarius subsp. coli (now S. lutetiensis) (on 17 isolates studied) were 156 
different from the data given by Schlegel, L. et al. (13, 20) especially regarding hydrolysis 157 
of esculin and acidity from glycogen, trehalose and starch. These different characteristics, 158 
together with the largest number of S. infantarius subsp. coli strains published, allowed 159 
Beck et al. to create an amended species description for S. infantarius subsp. coli (1). Also, 160 
the limitations of the 16S RNA sequencing to identify members of Streptococcus bovis 161 
group has been indicated by Poyart et al. (4). These authors pointed out that the 16S rDNA 162 
sequences of strains from S. infantarius sp coli were almost identical to those of the type of 163 
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S. bovis (99±9%) and S. infantarius (99±9%) strains. To differentiate such strains, these 164 
authors proposed the use of an alternative single-copy target sequence which exhibits 165 
greater sequence divergence than that of 16S rDNA: The sodA gene of the Gram-positive 166 
cocci, which encodes the manganese-dependent superoxide dismutase (Mn-SOD), allows 167 
differentiating closely related species belonging to the Streptococcus and Enterococcus 168 
(4,5) genera. 169 
In conclusion, we describe the first case of  S. lutetiensis isolate harbouring the InuB gene 170 
highlighting that antibiotic resistance in S. bovis group monitoring is necessary not only to 171 
detect new resistance mechanisms but also for a better therapeutic management when 172 
clindamycin is indicated.  173 
 174 
Nucleotide sequence accession number. The obtained sequences for the Streptococcus 175 
lutetiensis sodA and lnuB genes have been deposited at GenBank under accession numbers 176 
KC714048 and KC688833, respectively. 177 
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